This test is most useful if any of these apply to you.
This is a bacterium that belongs in your mouth. When a stool test finds it in your colon, an oral organism has made it the length of your digestive tract and turned up somewhere it normally can't hold on. That journey is the point of measuring it.
Researchers keep finding this species enriched in the stool of people with colorectal cancer, usually traveling with two or three other mouth bacteria. But this is a research marker, not a screening test. There's no standardized cutpoint, and a positive result doesn't mean you have cancer.
The lab is looking for an organism, and it finds one by its DNA. PCR copies a short stretch of bacterial genetic code over and over until there's enough of it to detect. The stretch usually comes from the 16S rRNA gene, which every bacterial species carries in a slightly different version, so the sequence works like a name tag.
Oxygen kills it. Its home is the tongue and the gum line, where it breaks down the amino acid cysteine into hydrogen sulfide. That reaction is why it's one of the better-documented causes of bad breath. Its scientific name has shifted over time, so the same organism appears in some databases under a second name.
A healthy gut isn't friendly to mouth bacteria. Stomach acid kills most of them on the way down, and the crowd already living in your colon squeezes out the survivors. Finding this species in stool suggests that defense has weakened somewhere. Researchers call the process oral-to-gut translocation.
This is the association that put the bacterium on the map. A large study that sequenced all the bacterial DNA in stool, comparing people with colorectal cancer against healthy controls, found this species consistently enriched in the cancer group. It was discovered in a Chinese cohort and held up in a separate Danish one. Few species survived that cross-population test.
It rarely travels alone. In the same analysis it clustered tightly with Parvimonas micra and Fusobacterium nucleatum, two other mouth organisms that turn up in cancerous colon tissue. A separate, smaller study comparing people with colorectal cancer to healthy controls found four oral species enriched in both the saliva and the stool of the cancer group, with this one among them.
Abundance also tracked with how far the disease had progressed. People with more advanced disease carried more of it than people with early-stage disease, in both saliva and stool. That pattern suggests the bacterium expands as the tumor environment develops rather than seeding the process at the start.
None of this establishes cause. The likeliest reading is that a tumor creates conditions, a broken gut lining and a different chemical environment, that an opportunistic mouth anaerobe can exploit. The bacterium looks like a passenger that boards only under certain conditions, and the researchers studying it say so directly.
If this bacterium drove cancer, carrying it in your mouth should predict getting cancer later. One prospective study checked exactly that, sampling the oral microbiome of low-income and African American participants before any diagnosis and following them forward. Baseline oral carriage of this species was associated with lower subsequent colorectal cancer incidence, though the finding didn't survive correction for the many comparisons the study made.
That reads as a contradiction only if you treat this as a high-is-bad number. It isn't one. It's a marker of where an organism is living. Carrying it in your mouth is ordinary; most people do. Finding it thriving in your colon is the unusual part, and the colon finding is the one tied to disease. Same bacterium, two different stories, because location is the variable that matters.
The strongest evidence for this organism has nothing to do with the gut. In the mouth it's repeatedly isolated from the tongue coating and saliva of people with persistent bad breath, and it's much less common in people without it. The hydrogen sulfide it makes from cysteine is the actual smell.
It also shows up in the deep pockets that form between tooth and gum in periodontal disease, in infected root canals, and in the mixed bacterial films that coat teeth alongside Porphyromonas gingivalis and Fusobacterium nucleatum. When it coexists with Fusobacterium, sulfur gas output runs higher than with either organism on its own. One study of students under exam stress found salivary levels of this species rose along with sulfur compound production.
That matters for reading a stool result. If oral bacteria are reaching your colon, the supply side is your mouth. Gum disease raises the load of oral anaerobes you swallow every day, and oral-to-gut translocation shows up more often in colorectal cancer cohorts. A stool positive is worth reading next to the state of your gums.
Occasionally this organism escapes the lining of the mouth or gut and reaches the blood. Reported cases are rare and almost always in people who were already seriously ill: blood cancers, pelvic tumors, severe immune suppression, injection drug use. It also turns up in mixed surgical wound infections, where it's one organism among several and the wound needs drainage regardless.
This is a hospital scenario, not something a stool result predicts. A stool positive in someone who feels well says nothing about bloodstream infection.
The fecal immunochemical test, FIT for short, looks for blood. It works only when a lesion is bleeding, which means it misses tumors that aren't bleeding on the day you collect. Even in screening cohorts, a single occult blood test leaves a meaningful share of cancers undetected.
Microbial testing looks for something else: a shift in which organisms live in your colon. That shift doesn't depend on bleeding. In the study that built a small PCR test from two of these oral organisms, Fusobacterium nucleatum and Parvimonas micra, the pair picked up a majority of the cancers present, and adding the bacterial measurement to occult blood testing caught more cancers than occult blood alone.
Note whose name is not on that test. This species was a strong discovery-stage marker, one of the organisms that kept coming up as predictive across populations. But when the researchers built the working assay, they used Fusobacterium and Parvimonas. How well this species performs on its own has never been established.
So nothing on this page substitutes for colonoscopy or FIT. This is a supplementary signal about your gut ecosystem. It doesn't tell you whether you have a polyp.
Gut microbiome composition swings with diet, medication, travel, illness, and stress. A single detection of one low-abundance species is close to noise. What carries information is whether it keeps showing up, and whether it's rising or falling.
No retest interval has been established, because nobody has studied this as a tracked marker. If you want a trend, a baseline and a second sample three to six months later is the practical approach, particularly if you're treating gum disease or making a sustained change to your diet, then roughly annually after that. If it appears once and is gone on the next two samples, you saw a transient. If it climbs across three, that's a pattern, and it's the kind of thing to raise with a gastroenterologist alongside your standard screening.
What a trend can't show is whether anything you did caused it. Direct evidence that any specific intervention moves this species in stool is thin. Treating gum disease shifts both oral and gut microbial composition in people with periodontitis, but those studies tracked the community as a whole, not this species by name in stool.
Start by checking whether the finding is isolated. This species matters most in company. If your panel also shows Fusobacterium nucleatum, Parvimonas micra, or Peptostreptococcus stomatis elevated, you're looking at the recurring oral-gut pattern rather than one stray organism. Alone, it means considerably less.
Then look at your mouth. A dental exam checking for gum inflammation and deep pockets around the teeth is the most direct follow-up available, because that's where the organism comes from.
Separately, and regardless of what this test says, get your standard colorectal screening on schedule. If you're 45 or older, or younger with a family history of colorectal cancer, inflammatory bowel disease, or an inherited condition that causes many colon polyps, colonoscopy is the test that settles the question. Rectal bleeding, unexplained anemia, a persistent change in bowel habit, or weight loss you didn't plan warrant a gastroenterologist now, not a repeat stool panel.
What not to do: treat this result as an infection. A positive stool PCR in someone who feels fine is not a reason for antibiotics. The organism is a normal resident of the human mouth, and the reported cases that warranted treatment involved bloodstream infections or wounds in already-ill patients, not stool findings.
Solobacterium Moorei is best interpreted alongside these tests.